APOC3 and Insulin resistance: Moreover, Kawakami et al. have shown in a series of experiments that apoC-III in VLDL activates peripheral monocytes and vascular endothelial cells with increased expression of adhesion molecules, induces insulin resistance in endothelial cells, and causes endothelial dysfunction [33].